Clincosm LogoSign in Get a demo

CLL

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

B-cell NHL, CLL Trial (CARCIK-CD19)

Not yet recruiting
  • B-cell NHL
  • CLL
  • CARCIK-CD19
  • (no location specified)
May 19, 2023

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
Has Results
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

B Cell NHL, CLL Trial in Sydney, Melbourne, Mount Pleasant (GB261)

Recruiting
  • B Cell NHL
  • CLL
  • GB261
  • Sydney, New South Wales, Australia
  • +4 more
Nov 16, 2022

Study of the Metabolism in the Lymphatic Niche of CLL

Recruiting
  • CLL
  • NO intervention
  • Nice, France
    Nice University Hospital
Nov 2, 2022

CLL Trial in Stony Brook, Oklahoma City (Zandelisib, Rituximab, Venetoclax)

Recruiting
  • CLL
  • Stony Brook, New York
  • +1 more
May 12, 2022

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    CLL, Vaccine Response Trial in Örebro (PCV13, PPSV23)

    Active, not recruiting
    • CLL
    • Vaccine Response
    • PCV13
    • PPSV23
    • Örebro, Sweden
      Magdalena Kättström
    Mar 29, 2022

    Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • +3 more
    • TP-0903
    • TP-0903 and ibrutinib combination therapy
    • Phoenix, Arizona
    • +5 more
    Apr 4, 2022

    Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
      • Bobigny, France
      • +8 more
      Mar 23, 2022

      Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

      Withdrawn
      • CLL
      • +4 more
      • Treatment Free Observation
      • Basking Ridge, New Jersey
      • +8 more
      Mar 4, 2022

      CLL, Leukemia Trial in Houston (Eltrombopag)

      Completed
      • CLL
      • Leukemia
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Mar 14, 2022

      Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

      Recruiting
      • Malignancy
      • +14 more
      • Scottsdale, Arizona
      • +17 more
      Mar 7, 2022

      Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

      Completed
      • CLL
        • Tampere, Finland
          Tampere university Hospital
        Feb 22, 2022

        Blood Pressure, Hypertension, Cancer Trial in Durham (Automated Messaging)

        Suspended
        • Blood Pressure
        • +6 more
        • Automated Messaging
        • Durham, North Carolina
          Duke University Medical Center
        Jan 21, 2022

        CLL, Chronic Lymphocytic Leukemia Trial in Milano, Torino (Peripheral blood samples withdrawal)

        Recruiting
        • CLL
        • Chronic Lymphocytic Leukemia
        • Peripheral blood samples withdrawal
        • Milano, Italy
        • +1 more
        Jan 3, 2022

        Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

        Withdrawn
        • Chronic Lymphocytic Leukemia
        • +8 more
        • Dose combination 1-1
        • +5 more
        • (no location specified)
        Nov 1, 2021

        Chronic Lymphocytic Leukemia, CLL Trial in La Jolla (Revlimid, Rituximab)

        Active, not recruiting
        Has Results
        • Chronic Lymphocytic Leukemia
        • CLL
        • La Jolla, California
          University of California, San Diego
        Sep 2, 2021

        CLL Trial in Denmark, Netherlands, Sweden (Acalabrutinib, Venetoclax)

        Recruiting
        • CLL
        • Copenhagen, Denmark
        • +5 more
        Sep 17, 2021

        CLL Trial in La Jolla (GA101/HDMP)

        Active, not recruiting
        • CLL
        • La Jolla, California
          UCSD Moores Cancer Center
        Sep 2, 2021

        CLL Trial in Denmark, Netherlands (ibrutinib, venetoclax, obinutuzumab, ibrutinib, venetoclax)

        Active, not recruiting
        • CLL
        • ibrutinib, venetoclax, obinutuzumab
        • ibrutinib, venetoclax
        • Aalborg, Denmark
        • +26 more
        Aug 20, 2021

        NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

        Completed
        • NHL
        • +17 more
        • veltuzumab
        • Savannah, Georgia
        • +4 more
        Aug 12, 2021